Cancer Researchers Shift Toward Degradation Strategies as Direct MCL-1 Inhibitors Stall
A comprehensive pharmacological review documents how cancer drug developers are moving away from direct MCL-1 inhibition toward targeted protein degradation ...
A comprehensive pharmacological review documents how cancer drug developers are moving away from direct MCL-1 inhibition toward targeted protein degradation ...
New research reveals that the membrane protein Annexin A6 regulates apoptotic priming and BCL-2 dependency in acute lymphoblastic leukaemia, with ...
A new cell study shows that C-phycocyanin can strip away Mcl-1-driven resistance and make the BH3-mimetic ABT-737 far more lethal ...
New research shows that BH3 mimetic drugs targeting antiapoptotic Bcl-2 family proteins can sensitize bladder cancer cells and patient-derived tumor ...
Researchers from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) have delivered a ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.